Quality Module QS I

...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...

Medicine Products:

Secobarbital Se, Serum Scopolamine, Serum or Plasma Schlichter Test

(Date:12/2/2008)..., Dec. 3 Minimally inva...se method for removal of self-inflicted,foreign o...t on "self-,embedding disorder," or self-injury a...scents. The findings will be presented today at th...orth America (RSNA). , "Radiologists are in...

(Date:12/2/2008)..., Mich., Dec. 3 Representatives fr...Machine.com ) paid a visit to the Shriners,Hospit...te to an,extraordinary, albeit unique, cause; The...eelchair-friendly exercise equipment to the first ... (Photo: http://www.newscom.com/cgi-bin/prnh/...

(Date:12/2/2008)...AN FRANCISCO, Calif., Dec. 1 diaDe...k approval for the automated format of the,PLAC T...(R) Test, capable of,running on a wide range of c...the U.S. Food & Drug Administration (FDA) in D...hipment of the CE Marked PLAC Test to Europe. , ...

(Date:12/2/2008)...ren of farm workers are three times as likely as a...her poor children to be uninsured, according to a ...rics & Adolescent Medicine, one of the JAMA/Archiv...ariety of health challenges, according to backgrou...group that already has suboptimal access to pediat...

Breaking Medicine News(10 mins):Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 2 Health News:Radiologists Diagnose and Treat Self-Embedding Disorder in Teens 3 Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2 Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2 Health News:1/3 of farm workers' children lack health insurance 2

[0] Radiologists Diagnose and Treat Self-Embedding Disorder in Teens [0] Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp [0] diaDexus Receives CE Mark Certification for the PLAC(R) Test [0] 1/3 of farm workers' children lack health insurance

...ws that people who have optic nerve damage are at ...volved 25 people with visual impairment. The parti...d for 14 days, and their results were compared wit...l sight. Researchers discovered those with optic n...

...ng the use of hormone replacement therapy among br...cause results indicate an unacceptably high rate o...barked on the study in part because more women are...ject to the same menopausal symptoms as other wome...

...common complaint and one that causes excessive abs... program // for these patients aimed at returning ...th lower back pain avoid exercise because of the p...e with low back pain can benefit from regular exer...

...s is a chronic inflammatory disease of the immune ... latest findings researchers say // people consumi...risk for rheumatoid arthritis . Researchers compa...awn from a research sample of over 25,000 men and ...

Other Medicine News:

The Link Between Eye Disease And Sleepiness The Link Between HRT And Recurrence of Breast Cancer Exercising The Best Form Of Treatment For Low Back Ache Consumption Of Red Meat Found To Double The Risk of Rheumatoid Arthritis

(Date:12/1/2008)...GO, Dec. 2 A study has ...new technique for imaging the breast, is not affec... status, two factors that limit the effectiveness ...r. Results will be presented today at the annual m...a (RSNA). , , "The ability of PEM to detec...

(Date:12/1/2008)...phatasia Treated With ENB-0040 at Children,s Hospi... MONTREAL, Dec. 1 Enobia Pharma, a...eloping novel therapeutics for serious bone disord... in its clinical program for hypophosphatasia was ...Therapy (ERT) with ENB-0040 for the treatment of t...

(Date:12/1/2008)...duled for Tuesday, December 9 at 11:00 am ET to Di...SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-...q: SNSS ), a biopharmaceutical company focused o...ology therapeutics, today announced new data from ... (AML) will be presented during the 50th American ...

(Date:11/28/2008)...November 28 German biotech company...cialized HIV monitoring and,AIDS patient follow-u...s. In,the year 2008, 2.5 million patient tests ha...ighly affordable "CyFlow" system, supporting alrea...S. Due to introduction of the,Partec innovation, ...

Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2 New Mammography Technology Effective in Detecting Breast Cancer 3 New Mammography Technology Effective in Detecting Breast Cancer 4 Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2 Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3 Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4 Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5 Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2 Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3 German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2 TopoTarget Successfully Buys Back Full Control of Belinostat 4752 1 TopoTarget Successfully Buys Back Full Control of Belinostat 4752 2 TopoTarget Successfully Buys Back Full Control of Belinostat 4752 3 TopoTarget Successfully Buys Back Full Control of Belinostat 4752 4 TopoTarget Successfully Buys Back Full Control of Belinostat 4752 5 TopoTarget Successfully Buys Back Full Control of Belinostat 4752 6 TopoTarget Successfully Buys Back Full Control of Belinostat 4752 7 Fufeng Announces 2007 Annual Results 4750 1 Fufeng Announces 2007 Annual Results 4750 2 Fufeng Announces 2007 Annual Results 4750 3 Ortho Evra Patch Makers Settling Cases 4749 1 Ortho Evra Patch Makers Settling Cases 4749 2 Europe spends nearly twice as much as US on nanotech risk research 4747 1 Europe spends nearly twice as much as US on nanotech risk research 4747 2

[1] New Mammography Technology Effective in Detecting Breast Cancer [0] Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease [0] Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH [0] German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008

... Therapeutics Inc.,(OTCBB:MIVT) (FWB:MIV), a leadi...ings and advanced drug delivery systems for,cardio...ces, today,announced that a recent Company sponsor...tific,s certified bare metal stent platform,which...r-free drug,delivery system met critical "FDA Draf...

...rograms to be Presented, SOUTH SAN FRANCISCO, Cali...inetics, Incorporated announced,today that four po...ed at the 2007 Annual Meeting of the American Asso... April 14- 18, 2007 in,Los Angeles, CA. These post...ytokinetics and will present data evaluating,ispin...

Other Medicine Technology:MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 2 MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 3 MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 4 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6 Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7

MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting

Products	Quality Module QS I
Company	PVT LabSystems LLC
Item	Quality Module QS I
Features	Tube Type Identification via Cap Recognition Control of serum regarding to the quantity and quality of the usable serum for Aliquoting Decrease of consumable costs by using generic pipetting tips (non-conductive)
Description	The Quality Module QS I evaluates and classifies the quality and quantity of centrifuged serum samples. The System analyses the tube, volume and cap and recognizes if a sample contains hemolytic, lipemic or icteric material. Combined with the Aliquoting System RSD 800A the use of cost saving non-conductive tips will be enabled.
Info	PVT LabSystems LLC Customer Service: +1 (404) 586-6837 Web site: http://www.pvtlabsystems.com/